Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Buffer Preparation for Harvest Operations – V 2.0

Posted on By


Biosimilars: SOP for Buffer Preparation for Harvest Operations – V 2.0


Standard Operating Procedure for Buffer Preparation for Harvest Operations in Biosimilar Manufacturing

Department Biosimilars
SOP No. SOP/BS/136/2025
Supersedes SOP/BS/136/2022
Page No. Page 1 of 10
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To define the procedure for the preparation, filtration, labeling, storage, and documentation of buffers used during harvest operations in biosimilar downstream processing to ensure product quality and GMP compliance.

2. Scope

This SOP applies to all personnel involved in buffer preparation for harvest clarification and primary purification processes, including centrifugation, depth filtration, and conditioning steps in the biosimilar manufacturing facility.

3. Responsibilities

  • Production: Prepare buffers as per batch requirements and SOP instructions.
  • QC: Perform pH and conductivity verification of prepared buffers.
  • QA: Review and approve buffer preparation records and confirm compliance.

4. Accountability

The Head of Manufacturing is accountable for ensuring buffer preparation is carried out as per validated procedures and documentation is complete before buffer release for use.

5. Procedure

5.1 Preparation and Planning

  1. Review the Buffer Preparation Instruction Sheet (Annexure-1) specific to each batch.
  2. Ensure availability of all raw materials (chemicals, WFI, etc.) and verified equipment (balances, mixers).
  3. Check expiry date and status label of raw materials before use.

5.2 Buffer Compounding

  1. Transfer WFI to the compounding vessel under controlled environment.
  2. Add chemicals slowly under mixing:
    • Use precision balances with proper tare.
    • Document each weight in Annexure-2: Buffer Compounding Log.
  3. Adjust pH using pre-approved acid/base solutions.
  4. Ensure complete dissolution before sampling.

5.3 In-Process Testing

  1. QC to perform:
    • pH check
    • Conductivity check
    • Appearance observation
  2. Record test results in Annexure-3: Buffer Testing Record.

5.4 Filtration and Storage

  1. Filter buffer through 0.22 µm sterilizing grade filters into cleaned and labeled containers.
  2. Label each container with:
    • Buffer Name
    • Batch No.
    • Date of Preparation
    • Expiry Date (as per validation)
  3. Store buffer under defined temperature and conditions.

5.5 Traceability and Documentation

  1. Attach preparation, testing, and release documents to the batch record.
  2. QA shall verify traceability of all buffer lots used in a batch during review.

6. Abbreviations

  • WFI: Water for Injection
  • QC: Quality Control
  • QA: Quality Assurance
  • GMP: Good Manufacturing Practice

7. Documents

  1. Buffer Preparation Instruction Sheet – Annexure-1
  2. Buffer Compounding Log – Annexure-2
  3. Buffer Testing Record – Annexure-3

8. References

  • EU GMP Chapter 5 – Production
  • WHO TRS 986 – GMP for Biotech Products
  • USP <1045> – Buffer Solutions

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Buffer Preparation Instruction Sheet

Buffer Name Components Target pH Volume
Harvest Buffer A NaCl, Tris 7.4 50 L

Annexure-2: Buffer Compounding Log

Date Buffer Name Material Weighed Qty Operator
04/05/2025 Harvest Buffer A NaCl 58.4 g Ajay Verma

Annexure-3: Buffer Testing Record

Buffer Name pH Conductivity Appearance QC Analyst
Harvest Buffer A 7.42 15.5 mS/cm Clear Sunita Reddy

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Added testing verification and label format Process optimization
See also  Biosimilars: SOP for Inline UV Absorbance Monitoring - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Conducting Process Capability Studies for Gels – V 2.0
Next Post: Analytical Method Development: SOP for In-Vitro Permeation Testing (IVPT) – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version